Jupiter Medical Center Offers First Of Its Kind Procedure To Treat Adults with Severe Asthma
Monday, October 9, 2017
Jacobson Strategic Communications
Jupiter Medical Center Offers First Of Its Kind Procedure
To Treat Adults with Severe Asthma
Bronchial Thermoplasty delivered by the Alair™ System
proven safe, effective and lasting in reducing asthma attacks
Jupiter, FL (October 9, 2017) — Jupiter Medical Center is pleased to announce that it now offers Bronchial Thermoplasty (BT) delivered by the Alair™ System. BT is a safe, outpatient procedure that is proven to reduce asthma attacks and emergency rooms visits for at least five years in adult patients with severe asthma, and is shown to improve asthma-related quality of life for people living with the disease.
“When Jupiter Medical Center learned about this innovative, proven technique that could improve the lives of people living in our community, we made it a priority to provide state-of-the-art technology to those who suffer from asthma,” said Steven Seeley, Interim President and CEO of Jupiter Medical Center. “We constantly strive to bring the highest quality healthcare to the community.”
In a clinical study, at year one compared to a control group, patients who had the BT procedure showed:
● a 32 percent reduction in severe asthma attacks
● an 84 percent reduction in emergency room visits for respiratory related symptoms
● 66 percent fewer days lost from work, school, and other activities due to asthma symptoms
More than 25 million people in the U.S. have asthma, and approximately 5-10% suffer from severe asthma. According to the Asthma and Allergy Foundation of America (AAFA), managing uncontrolled asthma consumes over $18 billion of health care resources each year. In the U.S. each year, asthma attacks result in approximately 10 million outpatient visits, two million emergency rooms visits, 500,000 hospitalizations, and 3,300 deaths.
Prior to the BT procedure, doctors had only pharmaceutical medications to offer their severe asthma patients, which offered temporary relief from asthma symptoms. Jupiter Medical Center now has this first-of-its-kind medical device procedure to provide severe asthma patients with a safe, long-lasting, proven treatment option to help reduce asthma attacks.
The treatment works by using controlled radiofrequency to heat up the lungs, coagulating the proteins in the smooth muscle fibers that can produce bronchial spams. The tissue then becomes weaker, lessening its ability to constrict the flow of oxygen.
“We want people suffering from asthma to know that this revolutionary treatment is available,” said Kenneth Fuquay, MD, Medical Director of the Sleep Center and Respiratory Services at Jupiter Medical Center. “Our goal is to get people back to their daily lives and this treatment makes that possible.”
The Bronchial Thermoplasty procedure is not a substitute for pharmaceutical medication as prescribed by a doctor. It works along with pharmaceuticals to provide less risk of asthma attacks and its complications for those suffering from severe asthma.
About Jupiter Medical Center
A not-for-profit 327-bed regional medical center consisting of 207 private acute-care hospital beds and 120 long-term care, sub-acute rehabilitation and Hospice beds, Jupiter Medical Center is reimagining how to restore the community’s health and wellness. Award-winning physicians, world-class partnerships and innovative techniques and technology enable Jupiter Medical Center to provide a broad range of services with specialty concentrations in cardiology, oncology, imaging, orthopedics & spine, digestive health, emergency and pediatric services, lung & thoracic, women’s health, weight management and men’s health.
Founded in 1979, Jupiter Medical Center has approximately 1,600 team members, 615 physicians and 640 volunteers. Jupiter Medical Center continues to perform in the top 10% of hospitals for patient quality and satisfaction. For more information on Jupiter Medical Center, please call (561) 263-2234 or visit jupitermed.com.
About Bronchial Thermoplasty Delivered by the Alair System
The Alair Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long acting beta agonists. The Alair System is not for use in patients with an active implantable electronic device or known sensitivity to medications used in bronchoscopy. Previously treated airways of the lung should not be retreated with the Alair System. Patients should be stable and suitable to undergo bronchoscopy. The most common side effect of Bronchial Thermoplasty is an expected temporary transient increase in the frequency and worsening of respiratory-related symptoms.